On a day when the chip complex is falling apart, one corner of the market is quietly green.
Health insurers are climbing while almost everything in tech sells off. Alignment Healthcare is up about 17% and trading near $18. The bigger names are setting fresh one-year highs even as the Nasdaq drops around 3%. This is what a rotation looks like in real time. Money is leaving expensive growth and moving into a group it ignored for two years.
The Move
UnitedHealth is trading near $410 and touched a 52-week high today. Elevance is near $421, also at a one-year high. Humana is around $358 and printing the same pattern. None of these are huge single-day moves, because defensive stocks rarely jump. The point is the direction. They are up on a day the market is down hard, and they are doing it from the highs, not off a bottom.
The recovery underneath these numbers is larger than today. UnitedHealth bottomed near $235 in the past year and now trades above $410. Humana's 52-week low was $163 against $358 today. These stocks spent 2024 and most of 2025 in the penalty box over rising medical costs. The trade now is that the worst is behind them.
One name shows the other side of the move. Oscar Health is down about 4% today after running more than 80% this year and tagging a fresh high earlier in the session. The smaller, faster insurers can reverse as quickly as they climb.
Why the Group Is Working
The catalyst for the move is Medicare Advantage. Insurers get paid by the government to cover seniors, and the 2026 rate updates came in stronger than the bearish case feared. Better rates mean wider margins on every member, and they reward the plans with the highest quality scores.
Alignment is the clearest example. The company says 100% of its members are in plans rated four stars or higher for the 2026 payment year, which qualifies it for bonus payments and helps keep members from leaving. It raised full-year guidance to revenue between $5.14 billion and $5.19 billion, growth of about 30%, and lifted its adjusted earnings outlook. The stock is also recovering from a stock sale earlier this year that had pushed it down.
The larger insurers benefit from the same rate backdrop with far less risk. Their medical loss ratios, the share of premiums paid out as claims, have started to settle after climbing through 2024 and 2025.
Valuation Is Doing Half the Work
The other half of this trade is price. UnitedHealth trades at roughly 31 times trailing earnings, pays a dividend yielding about 2.2%, and sells for less than one times revenue. Elevance and Humana trade at similar low multiples of sales. Compare that to the chip names being sold today, several of which trade above 20 times sales. When rates stay high, investors pay up for cash now instead of growth later, and insurers throw off steady cash.
Alignment is the exception and the warning. It is a small company near a $3.7 billion market value, it trades around 0.9 times sales like its peers, but it barely turns a profit, so its earnings multiple is meaningless and its swings are violent. The big insurers are the defensive trade. Alignment is a turnaround bet that happens to sit in the same sector.
There is real risk under all of this. Medicare Advantage rates are set by the government and can tighten in a future year. Medical costs can reaccelerate. Today's Oscar reversal is a reminder that the high-flyers in this group give back gains fast.
What to Watch
Tomorrow's CPI report at 8:30 AM Eastern sets the tone for every rate-sensitive corner of the market, and a hot print would keep the pressure on growth and the bid under defensives. Beyond that, watch whether this rotation holds for more than a single panicky session in tech, and whether the next round of Medicare Advantage details keeps the rate story pointed the right way. For now, the money leaving chips is landing somewhere, and a lot of it is landing here.
